We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Convey Health Solutions Holdings Inc | NYSE:CNVY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.51 | 0 | 01:00:00 |
Delaware
|
001-40506
|
84-2099378
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $0.01 par value per share
|
|
CNVY
|
|
New York Stock Exchange
|
Exhibit
No. |
Description
|
|
104
|
Cover Page Interactive Data File - The cover page from the Company’s Current Report on Form 8-K filed on June 21, 2022 is formatted in Inline
XBRL (included as Exhibit 101).
|
*
|
All schedules and exhibits to this agreement have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted
schedule and/or exhibit will be furnished supplementally to the SEC upon its request.
|
●
|
risks associated with transactions generally, such as the inability to obtain, or delays in obtaining, any required regulatory approvals or other
consents;
|
●
|
the failure to consummate or delay in consummating the Merger for other reasons;
|
●
|
the risk that a condition to closing of the Merger may not be satisfied;
|
●
|
the occurrence of any event, change or other circumstances that could give rise to the termination of the Agreement;
|
●
|
the outcome of any legal proceedings that may be instituted following announcement of the Merger;
|
●
|
failure of Parent to obtain the financing required to consummate the Merger;
|
●
|
failure to retain key management and employees of the Company;
|
●
|
issues or delays in the successful integration of the Company’s operations with those of Parent, including incurring or experiencing
unanticipated costs and/or delays or difficulties;
|
●
|
unfavorable reaction to the Merger by customers, competitors, suppliers and employees;
|
●
|
unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, war or hostilities or the COVID-19
pandemic, as well as management’s response to any of the aforementioned factors; and
|
●
|
additional factors discussed in the Company’s filings with the SEC.
|
|
CONVEY HEALTH SOLUTIONS HOLDINGS, INC.
|
|||
|
|
|||
|
|
|||
Date: June 21, 2022
|
By:
|
/s/ Timothy Fairbanks
|
||
|
Name:
|
Timothy Fairbanks | ||
|
Title:
|
Chief Financial Officer & Executive Vice President
|
1 Year Convey Health Solutions Chart |
1 Month Convey Health Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions